Whitehawk Therapeutics, Inc. - WHWK

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A OrbiMed Advisors LLC 7.3% 3,934,296 View
Aug 14, 2026 SCHEDULE 13G/A OrbiMed Genesis GP LLC 7.3% 3,934,296 View
Aug 14, 2026 SCHEDULE 13G/A ABG Management Ltd. 1.4% 817,939 View
Aug 14, 2026 SCHEDULE 13G/A Ally Bridge Group (NY) LLC 1.4% 817,939 View
Aug 14, 2026 SCHEDULE 13G/A Ally Bridge MedAlpha Master Fund L.P. 1.4% 817,939 View
Aug 14, 2026 SCHEDULE 13G/A ABG Innovation Capital Partners III GP Limited 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A ABG Innovation Capital Partners III GP, L.P. 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A Ally Bridge Group Innovation Capital Partners III, L.P. 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A ABG Innovation-SO Limited 0.0% 0 View
Aug 14, 2026 SCHEDULE 13G/A ABG Global Life Science Capital Partners V GP Limited 8.1% 4,861,314 View
Aug 14, 2026 SCHEDULE 13G/A ABG Global Life Science Capital Partners V GP, L.P. 8.1% 4,861,314 View
Aug 14, 2026 SCHEDULE 13G/A Ally Bridge Group Global Life Science Capital Partners V, L.P. 8.1% 4,861,314 View
Aug 14, 2026 SCHEDULE 13G/A ABG-SIV, L.P. 8.1% 4,861,314 View
Aug 14, 2026 SCHEDULE 13G/A ABG V-SIV Limited 8.1% 4,861,314 View
Aug 14, 2026 SCHEDULE 13G/A Fan Yu 9.4% 5,679,253 View
May 18, 2026 SCHEDULE 13D/A 8.7% 4,685,912 View
May 14, 2026 SCHEDULE 13D/A 19.99% 68,494,043 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.